Along with Dr Madeleine Duvic, MD, investigate the treatment of advanced folliculotropic mycosis fungoides and review the options available for patients with multiply relapsed disease.
Upon completion of this activity, participants should be able to:
Ibrutinib and the Management of Patients With del(17p) CLL
Current Controversies: Critical Decisions for Optimal Treatment of Multiple Myeloma
Salvage Therapy Prior to ASCT Improves Depth of Response but Not Survival in Patients With Newly Diagnosed MM
An Overview of New Diagnostic Criteria for Multiple Myeloma From the International Myeloma Working Group
Conference CoverageEducationClinicalThoughtDecision SupportCCO Live EventsSlidesets & Resources
Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.
Clinical Care Options, LLC. All Rights Reserved.